[China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015 3Q15 Added 17,622 New Subscribers 3Q15 Revenue Up 10.7% YOY to RMB166.7 Million ($26.9 Million) 3Q15 Operating Income Increased to RMB67.8 Million ($10.9 Million) Conference Call to be Held February 26, 2015 at 8:00 a.m. ET HONG KONG, China, February 25, 2015] [FORM 6-K For the month of February 2015 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Form 20-F x Form 40-F o o o Yes o No x EXPLANATORY NOTE Report on Report on Form 6-K are subject to risks, uncertainties and assumptions about the Company’s businesses and business environments. These statements reflect the Company’s current views]

[China Cord Blood Corporation Announces Results of 201 4 Annual General Meeting HONG KONG, China, December 11 , 201 4 - China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 201 4 Annual General Meeting,] [FORM 6-K 4 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On December 1 1 , 201 4]

[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2015 2Q15 Added 15,584 New Subscribers 2Q15 Revenue Up 7.4% YOY to RMB152.1 Million ($24.8 Million) 2Q15 Operating Income Increased to RMB57.5 Million ($9.4 Million) Conference Call to be Held November 26, 2014 at 8:00 a.m. ET HONG KONG, China, November 25, 2014 –] [EXPLANATORY NOTE Results of Operations and Financial Condition Following this cover page are the preliminary unaudited condensed consolidated financial results for the three months and six months ended September 30, 2014 of the Company. CHINA CORD BLOOD CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS As of March 31 and September 30, 2014]